Biggest News Aggregation in the World
📰 Caxton Corp News

Caxton Corp News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Caxton Corp. Real-time updates on events, politics, business and more.

Caxton Corp Has $2.61 Million Position in Rezolute, Inc. (NASDAQ:RZLT)

Caxton Corp reduced its holdings in Rezolute, Inc. (NASDAQ:RZLT – Free Report) by 6.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,318,967 shares of the company’s stock after selling 84,190 shares during the quarter. Rezolute accounts for 7.5% of Caxton Corp’s […]
United States Rezolute Inc Cantor Fitzgerald Northern Trust Corp Exchange Commission Caxton Corp

Caxton Corp Sells 46,599 Shares of Elevation Oncology, Inc. (NASDAQ:ELEV)

Caxton Corp decreased its holdings in shares of Elevation Oncology, Inc. (NASDAQ:ELEV – Free Report) by 68.2% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 21,725 shares of the company’s stock after selling 46,599 shares during the period. Elevation Oncology makes up approximately 0.1% of […]
Caxton Corp Blackrock Inc Annandale Capital Millennium Management Virtu Financial Elevation Oncology Inc

VectivBio Holding AG (NASDAQ:VECT) Sees Large Growth in Short Interest

VectivBio Holding AG (NASDAQ:VECT – Get Rating) was the target of a significant increase in short interest in March. As of March 15th, there was short interest totalling 105,400 shares, an increase of 85.9% from the February 28th total of 56,700 shares. Based on an average daily volume of 20,500 shares, the short-interest ratio is […]
United States Wells Fargo Company Barclays Plc Vectivbio Holding Caxton Corp National Bank

Cardiff Oncology (NASDAQ:CRDF) PT Lowered to $7.00

Cardiff Oncology (NASDAQ:CRDF – Get Rating) had its price objective dropped by investment analysts at Piper Sandler from $20.00 to $7.00 in a report released on Friday, The Fly reports. Piper Sandler’s price objective points to a potential upside of 442.64% from the stock’s previous close. A number of other brokerages have also recently issued […]
United States Piper Sandler Robertw Baird Cardiff Oncology Inc Geode Capital Management Life Insurance Co

$3.09 Million in Sales Expected for Kala Pharmaceuticals, Inc. (NASDAQ:KALA) This Quarter

Wall Street brokerages predict that Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Get Rating) will announce sales of $3.09 million for the current quarter, according to Zacks Investment Research. Six analysts have issued estimates for Kala Pharmaceuticals’ earnings, with estimates ranging from $2.04 million to $5.00 million. Kala Pharmaceuticals reported sales of $3.27 million during the same […]
United States Thomson Reuter Justin Hanes Kala Pharmaceuticals Get Rating Geode Capital Management Zacks Investment Research

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science